146 related articles for article (PubMed ID: 24969275)
41. Inflammatory bowel disease: the view of the surgeon.
Hancock L; Windsor AC; Mortensen NJ
Colorectal Dis; 2006 May; 8 Suppl 1():10-4. PubMed ID: 16594958
[TBL] [Abstract][Full Text] [Related]
42. Commonalities in the time trends of Crohn's disease and ulcerative colitis.
Delcò F; Sonnenberg A
Am J Gastroenterol; 1999 Aug; 94(8):2171-6. PubMed ID: 10445545
[TBL] [Abstract][Full Text] [Related]
43. [Indications for different collagen metabolism in Crohn disease and ulcerative colitis].
Matthes H; Stallmach A; Matthes B; Herbst H; Schuppan D; Riecken EO
Med Klin (Munich); 1993 Apr; 88(4):185-92. PubMed ID: 8492773
[TBL] [Abstract][Full Text] [Related]
44. [Therapy progression in surgery of inflammatory bowel diseases].
Zuo S; Wang X; Liu YC; Wang PY
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Aug; 15(8):872-6. PubMed ID: 22941697
[TBL] [Abstract][Full Text] [Related]
45. Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis.
Svrcek M; Cosnes J; Beaugerie L; Parc R; Bennis M; Tiret E; Fléjou JF
Histopathology; 2007 Apr; 50(5):574-83. PubMed ID: 17394493
[TBL] [Abstract][Full Text] [Related]
46. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
[TBL] [Abstract][Full Text] [Related]
47. Patient-relevant endpoints in inflammatory bowel diseases--have changes occurred in Germany over the past twelve years?
Stallmach A; Dennler U; Marschall U; Schmidt C
J Crohns Colitis; 2015 May; 9(5):390-7. PubMed ID: 25740812
[TBL] [Abstract][Full Text] [Related]
48. Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis.
Odes HS; Fich A; Reif S; Halak A; Lavy A; Keter D; Eliakim R; Paz J; Broide E; Niv Y; Ron Y; Villa Y; Arber N; Gilat T
Dig Dis Sci; 2001 Aug; 46(8):1717-21. PubMed ID: 11508673
[TBL] [Abstract][Full Text] [Related]
49. Recent developments in "nonspecific" inflammatory bowel disease (first of two parts).
Kirsner JB; Shorter RG
N Engl J Med; 1982 Apr; 306(13):775-85. PubMed ID: 7038488
[No Abstract] [Full Text] [Related]
50. Colorectal carcinoma in indeterminate colitis.
Branco BC; Harpaz N; Sachar DB; Greenstein AJ; Tabrizian P; Bauer JJ; Greenstein AJ
Inflamm Bowel Dis; 2009 Jul; 15(7):1076-81. PubMed ID: 19177428
[TBL] [Abstract][Full Text] [Related]
51. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort.
Ho GT; Chiam P; Drummond H; Loane J; Arnott ID; Satsangi J
Aliment Pharmacol Ther; 2006 Jul; 24(2):319-30. PubMed ID: 16842459
[TBL] [Abstract][Full Text] [Related]
52. Dermatologic manifestations of inflammatory bowel disease: a review.
Keyal U; Liu Y; Bhatta AK
Discov Med; 2018 May; 25(139):225-233. PubMed ID: 29906405
[TBL] [Abstract][Full Text] [Related]
53. Progress and frustration in inflammatory bowel disease.
Brooke BN
Ann R Coll Surg Engl; 1980 Nov; 62(6):432-8. PubMed ID: 7002013
[TBL] [Abstract][Full Text] [Related]
54. Colectomy in children with ulcerative and granulomatous colitis.
Frey CF; Weaver DK
Arch Surg; 1972 Apr; 104(4):416-23. PubMed ID: 5013778
[No Abstract] [Full Text] [Related]
55. [Evolving therapeutic targets in inflammatory Bowel Disease: mucosal healing as an emerging end point].
Condino G; Margagnoni G; Aratari A; Luchetti R; Papi C
Recenti Prog Med; 2015 Nov; 106(11):564-9. PubMed ID: 26668042
[TBL] [Abstract][Full Text] [Related]
56. [Therapy of inflammatory bowel disease].
Vucelic B
Med Arh; 2002; 56(1 Suppl 1):37-45. PubMed ID: 12055723
[TBL] [Abstract][Full Text] [Related]
57. Eosinophilic gastrointestinal disease and inflammatory bowel disease in children: is it a disease continuum?
Mutalib M; Blackstock S; Evans V; Huggett B; Chadokufa S; Kiparissi F; Elawad M
Eur J Gastroenterol Hepatol; 2015 Jan; 27(1):20-3. PubMed ID: 25358014
[TBL] [Abstract][Full Text] [Related]
58. Spleen size in patients with inflammatory bowel disease. Does it have any clinical significance?
Pereira JL; Hughes LE; Young HL
Dis Colon Rectum; 1987 Jun; 30(6):403-9. PubMed ID: 3595356
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic potential of flavonoids in inflammatory bowel disease: A comprehensive review.
Salaritabar A; Darvishi B; Hadjiakhoondi F; Manayi A; Sureda A; Nabavi SF; Fitzpatrick LR; Nabavi SM; Bishayee A
World J Gastroenterol; 2017 Jul; 23(28):5097-5114. PubMed ID: 28811706
[TBL] [Abstract][Full Text] [Related]
60. [Refractory inflammatory bowel disease: surgical challenges].
Buhr HJ; Kroesen AJ
Chirurg; 2013 Nov; 84(11):945-50. PubMed ID: 24170117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
